Evidence map›Paper›PMID 38446248›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Open communication between patients and relatives about illness & death in advanced cancer-results of the eQuiPe Study.

Michelle Haaksman, Laurien Ham, Linda Brom, Arnold Baars, Jean-Paul van Basten, Ben E E M van den Borne, Mathijs P Hendriks, Wouter K de Jong, Hanneke W M van Laarhoven, Anne S R van Lindert and 6 more

Abstract readMulticenter Study
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Michelle HaaksmanDepartment of Health, Medical and Neuropsychology, University of Leiden, Leiden, the Netherlands. n.raijmakers@iknl.nl.
Laurien HamDepartment of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), PO box 19079, 3501, DB, Utrecht, the Netherlands.
Linda BromDepartment of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), PO box 19079, 3501, DB, Utrecht, the Netherlands.
Arnold BaarsDepartment of Internal Medicine, Hospital Gelderse Vallei, Ede, the Netherlands.
Jean-Paul van BastenDepartment of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Ben E E M van den BorneDepartment of Pulmonology, Catharina Hospital, Eindhoven, the Netherlands.
Mathijs P HendriksDepartment of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands.
Wouter K de JongDepartment of Pulmonology, Hospital Gelderse Vallei, Ede, the Netherlands.
Hanneke W M van LaarhovenDepartment of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
Anne S R van LindertDepartment of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands.
Caroline M P W MandigersDepartment of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Annemieke van der Padt-PruijstenDepartment of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.
Tineke J SmildeDepartment of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Lia C van ZuylenDepartment of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
Liesbeth M van VlietDepartment of Health, Medical and Neuropsychology, University of Leiden, Leiden, the Netherlands.
Natasja J H RaijmakersDepartment of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), PO box 19079, 3501, DB, Utrecht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the degree of openness of communication about illness and death between patients with advanced cancer and their relatives during the last three months of the patient's life, and its association with relatives' characteristics and bereavement distress.

methodsWe used data from bereaved relatives of patients with advanced cancer from the prospective, longitudinal, multicenter, observational eQuipe study. Univariate and multivariable linear regression analyses were used to assess the association between the degree of openness of communication (measured using the validated Caregivers' Communication with patients about Illness and Death scale), the a priori defined characteristics of the relatives, and the degree of bereavement distress (measured using the Impact of Event Scale).

resultsA total of 160 bereaved relatives were included in the analysis. The average degree of open communication about illness and death between patients with advanced cancer and their relatives was 3.86 on a scale of 1 to 5 (SE=0.08). A higher degree of open communication was associated with a lower degree of bereavement distress (p=0.003). No associations were found between the degree of open communication and the relatives' age (p=0.745), gender (p=0.196), level of education (p>0.773), (religious) worldview (p=0.435), type of relationship with the patient (p>0.548), or level of emotional functioning before the patient's death (p=0.075).

conclusionsOpen communication about illness and death between patients and relatives seems to be important, as it is associated with a lower degree of bereavement distress. Healthcare professionals can play an important role in encouraging the dialogue. However, it is important to keep in mind that some people not feel comfortable talking about illness and death.

Indexed as

BereavementNeoplasmsCommunicationGriefHumansProspective StudiesBereavementCancerCommunicationOncologyPalliative careRelatives

Identifiers

PMID38446248
PMCPMC10917842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.